EGFR signaling is a major contributor of PASMC proliferation, migration, and survival, and an EGFR inhibitor was shown to ameliorate pulmonary arterial remodeling in monocrotaline-induced PAH rat28. Here, EGFR is linked to pulmonary arterial hypertension.